Pharma company ranking by access to medicine management in developing countries 2018

This statistic depicts the pharmaceutical company ranking based on general access to medicine management in developing countries in 2018, according to the Access to Medicine Index 2018. In that year, the company with the highest score in this category was Novartis AG, with a total indicator score of 4.56. The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.

Pharmaceutical company ranking based on general access to medicine management in developing countries in 2018*

Indicator score from 1 (lowest) to 5 (highest)
Novartis AG4.56
Roche Holding Ltd. 4.52
GlaxoSmithKline plc4.26
Johnson & Johnson4.12
Novo Nordisk A/S3.98
Takeda Pharamceutical Co.3.7
Sanofi3.52
Merck KGaA3.42
Pfizer Inc.3.4
Merck & Co. Inc.3.34
AstraZeneca plc3.26
Eisai Co. Ltd.3.08
Bristol-Myers Squibb Co.3.06
Eli Lilly & Co.3
AbbVie Inc.2.86
Bayer AG2.79
Boehringer-Ingelheim GmbH2.63
Gilead Sciences2.23
Daiichi Sankyo Co. Ltd.1.9
Astellas Pharma Inc.1.82
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

November 2018

Region

Worldwide

Survey time period

2018

Supplementary notes

* The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
The Index uses a framework that evaluates company activities in seven areas of activity, or technical areas, considered to be key to enhancing access to medicine in developing countries, and across four important aspects of action, or strategic pillars.
A score of zero means lowest and five signifies highest indicator score among the company set.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Monsanto-Bayer"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.